Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Graham

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Pediatric Infectious Disease Journal|September 10, 2009
Kawasaki disease without feverClaas H Hinze, Thomas B Graham, Jamie S Sutherell
Neurology. Clinical Practice|January 4, 2024
Anti-NMDAR Encephalitis Clinical Practice Guideline: Improving Time to Diagnosis, Treatment, and Hospital Length of StayKelsey M Barter, Catherine Fuchs, Thomas B Graham, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 19, 2021
Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients With Juvenile Idiopathic ArthritisAndrea M Goettel, Josh DeClercq, Leena Choi, et al.
The Journal of Pain|November 19, 2003
Depression, coping, and functional disability in juvenile primary fibromyalgia syndromeSusmita Kashikar-Zuck, Michelle H Vaught, Kenneth R Goldschneider, et al.
Arthritis Research & Therapy|January 12, 2005
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndromeJoyce Villanueva, Susan Lee, Edward H Giannini, et al.
Arthritis Care & Research|July 1, 2021
Juvenile Fibromyalgia in Patients With Juvenile Idiopathic Arthritis: Utility of the Pain and Symptom Assessment ToolMelissa S Tesher, Thomas B Graham, Tracy Ting, et al.
AJR. American Journal of Roentgenology|September 23, 2010
T2 relaxation time changes in distal femoral articular cartilage in children with juvenile idiopathic arthritis: a 3-year longitudinal studyHee Kyung Kim, Tal Laor, Thomas B Graham, et al.
Orthopedics|July 25, 2022
Chronic Recurrent Multifocal Osteomyelitis: A Review of the Noninfectious Inflammatory Bone Disease and Lessons for More Timely DiagnosisJeffrey C Krout, Andrew B Rees, Amanda N Goldin, et al.
Arthritis and Rheumatism|March 1, 2007
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisJack Bleesing, Anne Prada, David M Siegel, et al.
Arthritis Care & Research|September 11, 2023
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung DiseaseYannan Huang, Laura Sompii-Montgomery, Jessica Patti, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Pediatric Infectious Disease Journal|September 10, 2009
Kawasaki disease without feverClaas H Hinze, Thomas B Graham, Jamie S Sutherell
Neurology. Clinical Practice|January 4, 2024
Anti-NMDAR Encephalitis Clinical Practice Guideline: Improving Time to Diagnosis, Treatment, and Hospital Length of StayKelsey M Barter, Catherine Fuchs, Thomas B Graham, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 19, 2021
Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients With Juvenile Idiopathic ArthritisAndrea M Goettel, Josh DeClercq, Leena Choi, et al.
The Journal of Pain|November 19, 2003
Depression, coping, and functional disability in juvenile primary fibromyalgia syndromeSusmita Kashikar-Zuck, Michelle H Vaught, Kenneth R Goldschneider, et al.
Arthritis Research & Therapy|January 12, 2005
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndromeJoyce Villanueva, Susan Lee, Edward H Giannini, et al.
Arthritis Care & Research|July 1, 2021
Juvenile Fibromyalgia in Patients With Juvenile Idiopathic Arthritis: Utility of the Pain and Symptom Assessment ToolMelissa S Tesher, Thomas B Graham, Tracy Ting, et al.
AJR. American Journal of Roentgenology|September 23, 2010
T2 relaxation time changes in distal femoral articular cartilage in children with juvenile idiopathic arthritis: a 3-year longitudinal studyHee Kyung Kim, Tal Laor, Thomas B Graham, et al.
Orthopedics|July 25, 2022
Chronic Recurrent Multifocal Osteomyelitis: A Review of the Noninfectious Inflammatory Bone Disease and Lessons for More Timely DiagnosisJeffrey C Krout, Andrew B Rees, Amanda N Goldin, et al.
Arthritis and Rheumatism|March 1, 2007
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisJack Bleesing, Anne Prada, David M Siegel, et al.
Arthritis Care & Research|September 11, 2023
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung DiseaseYannan Huang, Laura Sompii-Montgomery, Jessica Patti, et al.
Pageof 1